Global ECMO Devices Market Strategic Research Report

Scope of the Report

The global ECMO Devices market size is predicted to grow from US$ 271 million in 2025 to US$ 346 million in 2032; it is expected to grow at a CAGR of 3.6% from 2026 to 2032.

Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.

Market Drivers:

Rising Incidence of Cardiopulmonary Disorders:

Increasing cases of respiratory and cardiac diseases, such as chronic obstructive pulmonary disease (COPD), heart failure, and acute respiratory distress syndrome (ARDS), drive demand for ECMO devices. These devices are essential for patients whose heart and lungs need support, especially during severe cases or surgeries.

Advancements in ECMO Technology:

Innovations like portable ECMO devices, improved oxygenators, and better control systems have enhanced the safety and effectiveness of ECMO therapy, expanding its applications and encouraging adoption in a broader range of healthcare settings.

Increasing Use in COVID-19 and Critical Care:

The COVID-19 pandemic highlighted the need for advanced respiratory support for patients with severe respiratory failure. ECMO became a critical intervention in some severe cases, increasing awareness and demand for these devices.

Growing Use in Pediatric and Neonatal Care:

ECMO devices are increasingly being used in neonatal and pediatric ICUs to support infants with congenital heart disease or respiratory failure, expanding the market across different age groups.

Rising Number of Specialized Healthcare Facilities:

The increase in specialized healthcare centers, especially in developed economies, has made ECMO therapy more accessible, as these devices are often only available in well-equipped, high-acuity centers.

Market Challenges:

High Cost of ECMO Therapy and Devices:

ECMO treatment and the devices themselves are expensive, making them less accessible, particularly in low-income regions or countries with limited healthcare budgets. This limits adoption to only the most severe cases and to hospitals that can afford the technology.

Requirement of Skilled Professionals:

ECMO procedures are complex and require specialized training for operation and monitoring. A shortage of trained ECMO technicians and specialists poses a significant challenge, as improper handling can lead to serious complications.

Risk of Complications:

ECMO therapy has associated risks, such as bleeding, infection, and clotting issues, which can deter its usage in certain patients or situations. These risks require close monitoring and increase the need for experienced healthcare staff.

Strict Regulatory Standards:

ECMO devices are subject to stringent regulations by authorities like the FDA, which requires extensive testing for safety and efficacy. These regulatory hurdles can delay product approvals and increase costs for manufacturers.

Limited Awareness and Accessibility in Developing Regions:

In emerging markets, awareness about ECMO technology and access to it are limited due to a lack of trained professionals and high treatment costs. This restricts the market potential in regions where the healthcare infrastructure is less developed.

Global players of ECMO Devices include Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo and Fresenius Medical Care. Medtronic is the largest player, with a share about 34%. North America is the largest market, with a share about 40%, followed by Europe and China. In terms of product, VV (Veno-Venous) ECMO is the largest segment, with a share over 70%. In terms of application, Adult is the largest market, with a share about 80%.

This report presents a comprehensive overview of the global ECMO Devices market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• VA (Veno-Arterial) ECMO
• VV (Veno-Venous) ECMO

Segment by Application

• Adult
• Neonatal
• Pediatric

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global ECMO Devices market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Adult, Neonatal, Pediatric evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact